Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026
Globe Newswire•22/10/2026•16:01 ET
0
Key Highlights
- ➤Denali (DNLI) will report Q3 2026 financial results on November 3, 2026
- ➤Management will provide a general business update during the November 3 conference call
- ➤Webcast and slide presentation will be available through Denali’s Investors website
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will report financial results and business highlights for the third quarter ended September 30, 2026, on Tuesday, November 3, 2026.
Denali’s management will host a conference call and webcast on Tuesday, November 3, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss third quarter 2026 financial results and provide a general business update.
Get started
Create a free account to read the full story.